Training innate immunity: The changing concept of immunological memory in innate host defence

European Journal of Clinical Investigation

Volumn 43, Issue 8, 2013, Pages 881-884

  Netea, Mihai G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Immunological memory; Trained immunity; Vaccine

Indexed keywords

BCG VACCINE; MEASLES VACCINE;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; EPIGENETICS; HOST RESISTANCE; HUMAN; IMMUNOLOGICAL MEMORY; INNATE IMMUNITY; MACROPHAGE; MEASLES; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 84880711233     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12132     Document Type: Review

References (27)

1. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010;140:805-20.
2. Netea MG, Quintin J, van der Meer JW. Trained immunity: a memory for innate host defense. Cell Host Microbe 2011;9:355-61.
3. Durrant WE, Dong X. Systemic acquired resistance. Annu Rev Phytopathol 2004;42:185-209.
4. Pham LN, Dionne MS, Shirasu-Hiza M, Schneider DS. A specific primed immune response in Drosophila is dependent on phagocytes. PLoS Pathog 2007;3:e26.
5. Kurtz J. Specific memory within innate immune systems. Trends Immunol 2005;26:186-92.
6. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature 2009;457:557-61.
7. Paust S, Gill HS, Wang BZ, Flynn MP, Moseman EA, Senman B et al. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat Immunol 2010;11:1127-35.
8. Quintin J, Saaed S, Martens JHA, Giamarellos-Bourboulis EJ, Ifrim DC, Logie C et al. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 2012;12:223-232.
9. Bowdish DM, Loffredo MS, Mukhopadhyay S, Mantovani A, Gordon S. Macrophage receptors implicated in the "adaptive" form of innate immunity. Microbes Infect 2007;9:1680-7.
10. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL et al. Innate or adaptive immunity? The example of natural killer cells. Science 2011;331:44-9.
11. van den Burg HA, Takken FL. Does chromatin remodeling mark systemic acquired resistance? Trends Plant Sci 2009;14:286-94.
12. Heremans H, Van Damme J, Dillen C, Dijkmans R, Billiau A. Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J Exp Med 1990;171:1853-69.
13. Boehm T, McCurley N, Sutoh Y, Schorpp M, Kasahara M, Cooper MD. VLR-based adaptive immunity. Annu Rev Immunol 2012;30:203-20.
14. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007;7:379-90.
15. Philbin VJ, Dowling DJ, Gallington LC, Cortés G, Tan Z, Suter EE et al. Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways. J Allergy Clin Immunol 2012;130:195-204 e9.
16. Conrath U. Molecular aspects of defence priming. Trends Plant Sci 2011;16:524-31.
17. Slaughter A, Daniel X, Flors V, Luna E, Hohn B, Mauch-Mani B. Descendants of primed Arabidopsis plants exhibit resistance to biotic stress. Plant Physiol 2012;158:835-43.
18. Bistoni F, Vecchiarelli A, Cenci E, Puccetti P, Marconi P, Cassone A. Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infect Immun 1986;51:668-74.
19. Lopez-Verges S, Milush JM, Schwartz BS, Pando MJ, Jarjoura J, York VA et al. Expansion of a unique CD57(+)NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci USA 2011;108:14725-32.
20. Maitra U, Deng H, Glaros T, Baker B, Capelluto DG, Li Z et al. Molecular mechanisms responsible for the selective and low-grade induction of proinflammatory mediators in murine macrophages by lipopolysaccharide. J Immunol 2012;189:1014-23.
21. Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007;447:972-8.
22. Ostuni R, Piccolo V, Barozzi I, Polletti S, Termanini A, Bonifacio S et al. Latent enhancers activated by stimulation in differentiated cells. Cell 2013;152:157-71.
23. Barton ES, White DW, Cathelyn JS, Brett-McClellan KA, Engle M, Diamond MS et al. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 2007;447:326-9.
24. van't Wout JW, Poell R, van Furth R. The role of BCG/PPD-activated macrophages in resistance against systemic candidiasis in mice. Scand J Immunol 1992;36:713-19.
25. Spencer JC, Ganguly R, Waldman RH. Nonspecific protection of mice against influenza virus infection by local or systemic immunization with Bacille Calmette-Guerin. J Infect Dis 1977;136:171-5.
26. Aaby P, Roth A, Ravn H, Napirna BM, Rodrigues A, Lisse IM et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J Infect Dis 2011;204:245-52.
27. Roth AE, Stensballe LG, Garly ML, Aaby P. Beneficial non-targeted effects of BCG-ethical implications for the coming introduction of new TB vaccines. Tuberculosis (Edinb) 2006;86:397-403.